Mitochondrial DNA mutations in Alzheimer's disease

Biochemical and Biophysical Research Communications
T P HutchinA J Sinclair

Abstract

Several reports have indicated that point mutations of the mitochondrial DNA (mtDNA) contribute to the pathogenesis of Alzheimer's disease (AD). However, other groups have failed to find similar associations between these mutations and AD. A recent report described a set of mutations in the mtDNA encoded cytochrome oxidase genes which may account for 20% of all AD cases. We screened brain tissue from 65 AD patients for each of these previously reported mtDNA mutations but were unable to find an increased incidence of any of them in our AD sample. However, one patient with a mutation in the APP gene did harbour a novel mtDNA mutation (G to C at position 5705 in the tRNAAsn gene) that might have contributed to the very early onset of dementia in this individual. The role of mtDNA mutations in the pathogenesis of AD remains unclear, but they do not appear to be primary causes but may contribute to the onset of the disease.

Citations

Apr 8, 1999·Molecular Pathology : MP·L TilleyN Kalsheker
Mar 12, 1999·Annual Review of Medicine·D K Simon, D R Johns
Oct 31, 2002·Human Psychopharmacology·Kurt Heininger
Aug 5, 2004·European Journal of Human Genetics : EJHG·Howard T JacobsRobert F Mueller
Jul 10, 2018·International Journal of Geriatric Psychiatry·Gregory J TranahUNKNOWN Health, Aging and Body Composition Study
Oct 23, 2002·Journal of Neuroscience Research·Rudy CastellaniMark A Smith
May 10, 2006·Genes, Brain, and Behavior·M GrazinaC Oliveira
Dec 17, 2008·Annals of the New York Academy of Sciences·Elza KhusnutdinovaDouglas C Wallace
Jan 3, 2019·The Journal of Clinical Investigation·Estela Area-GomezSerge Przedborski
Apr 26, 2005·Aging Clinical and Experimental Research·Jordi CasademontFrancesc Cardellach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.